Citation: | WANG Di. Relationship of hs-CRP with severity of coronary atherosclerosis and prognosis in coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2013, (15): 96-97,102. DOI: 10.7619/jcmp.201315035 |
Heart Protection Study Collaborative Group, Jonathan Emberson, Derrick Bennett. C-reactive protein concentration and the vascular benefits of statin therapy:an analysis of 20, 536 patients in the Heart Protection Study [J]. Lancet, 2011, (9764):469.
|
秦继宝, 吴兆增. hs-CRP、GMP-140和cTn Ⅰ联检在CHD患者的应用 [J]. 放射免疫学杂志, 2010(5):498.doi: 10.3969/j.issn.1008-9810.2010.05.009.
|
招钜泉, 谢冰, 袁程伟. 血清CTn-Ⅰ和Hs-CRP联合检测在冠心病中的应用价值 [J]. 中国当代医药, 2010, (22):60.doi: 10.3969/j.issn.1674-4721.2010.22.032.
|
周林, 张晶. 老年冠心病患者冠脉病变与hs-CRP、BNP的相关性 [J]. 江苏医药, 2010, (23):2759.
|
漆军华, 王晓华. 同型半胱氨酸、超敏C反应蛋白、纤维蛋白原与冠心病的相关性研究 [J]. 实用临床医学, 2009(7):4.doi: 10.3969/j.issn.1009-8194.2009.07.002.
|
Fraser A, May M, Lowe G. Interleukin-6 and incident coronary heart disease:results from the British Women's Heart and Health Study [J]. Atheroclerosis, 2009(2):567.
|